A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine in admixture is administered three times per day.

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. In some embodiments the ibuprofen is in direct physical contact with the famotidine.

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.

Pharmaceutical compositions of a H2 receptor antagonist and ibuprofen are provided herein. The compositions comprise e.g. a core and a shell separated by a barrier layer bilayered or trilayered compositions or liquid formulations. Also provided are methods of making the pharmaceutical compositions and methods of treatment comprising administering the pharmaceutical compositions. Also provided is a method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in w...

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.